Polymorphonuclear leukocyte membrane fluidity before and after activation in subjects with insulin resistance

被引:9
作者
Caimi, G
Sinagra, D
Canino, B
Scarpitta, AM
Montana, M
Bonaventura, W
Lo Presti, R
机构
[1] Univ Palermo, Inst Clin Med & Cardiovasc Dis, I-90127 Palermo, Italy
[2] Univ Palermo, Inst Clin Med, I-90127 Palermo, Italy
关键词
euglycemic hyperinsulinemic clamp; obesity; type 2 diabetes mellitus; acanthosis nigricans;
D O I
10.1007/s005920070029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this research was the evaluation of polymorphonuclear leukocyte (PMN) membrane fluidity in subjects with insulin resistance. Insulin sensitivity, in fact, may be influenced by plasma membrane fluidity. We enrolled 19 subjects with insulin resistance previously demonstrated during an euglycemic hyperinsulinemic clamp. PMN membrane fluidity was studied by labeling intact cells with the fluorescent probe 1-[4-(trimethylamino)phenyl] -6-phenyl-1,3,5-hexatriene and calculating the fluorescence polarization degree. The measurement was made before and after incubation of PMNs with two activating agents: 4-phorbol 12-myristate 13-acetate (PMA) and N-formyl-methionyl-leucyl-phenylalanine (fMLP). The baseline data showed a reduction of PMN membrane fluidity in subjects with insulin resistance. After PMN activation with PMA and fMLP, no significant variation in membrane fluidity was present in PMNs from normals, while in those from subjects with insulin resistance a slight decrease in PMN membrane fluidity was found only after activation with fMLP. The behavior of PMN membrane fluidity, before and after activation, distinguishes insulin-resistant subjects from normal controls, although the effect cannot be directly correlated with the degree of insulin resistance.
引用
收藏
页码:9 / 12
页数:4
相关论文
共 36 条
[1]  
[Anonymous], 1997, WHO TECHN REP SER
[2]   ALTERATION OF ERYTHROCYTE-MEMBRANE LIPID FLUIDITY IN HUMAN OBESITY [J].
BEGUINOT, F ;
TRAMONTANO, D ;
DUILIO, C ;
FORMISANO, S ;
BEGUINOT, L ;
MATTIOLI, P ;
MANCINI, M ;
ALOJ, SM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (06) :1226-1230
[3]   CHANGES IN MEMBRANE MICROVISCOSITY ASSOCIATED WITH PHAGOCYTOSIS - EFFECTS OF COLCHICINE [J].
BERLIN, RD ;
FERA, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (03) :1072-1076
[4]   Protein kinase C isoforms beta 1 and beta 2 inhibit the tyrosine kinase activity of the insulin receptor [J].
Bossenmaier, B ;
Mosthaf, L ;
Mischak, H ;
Ullrich, A ;
Haring, HU .
DIABETOLOGIA, 1997, 40 (07) :863-866
[5]  
Caimi G, 1998, CLIN HEMORHEOL MICRO, V19, P281
[6]  
Caimi G, 1997, CLIN HEMORHEOL MICRO, V17, P217
[7]  
CAIMI G, 1991, MICROCIRC ENDOTH LYM, V7, P293
[8]  
Caimi G, 1996, CLIN HEMORHEOL, V16, P523
[9]   Type II diabetics with macrovascular complications:: Polymorphonuclear leukocyte (PMM) filtration, PMN membrane fluidity and cytosolic Ca2+ content after activation [J].
Caimi, G ;
Lo Presti, R ;
Montana, M ;
Ferrara, F ;
Ventimiglia, G ;
Meli, F ;
Catania, A ;
Canino, B .
HORMONE AND METABOLIC RESEARCH, 1998, 30 (02) :72-76
[10]  
CANDILOROS H, 1995, LANCET, V345, P994, DOI 10.1016/S0140-6736(95)90746-7